We also tested the influence of CXCL12 on two other mutant p53-expressing breast cancer cell lines, MDA-MB-468 and T47D, and the wild-type p53-expressing breast cancer cell line MCF7 (Figure S1). This evidence concerns the gene TP53 and breast carcinoma.